- BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
- BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
- BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
- BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
- BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
- BioAtla to Participate in the Jefferies London Healthcare Conference
- BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award
- BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
- BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
- BioAtla to Participate in Upcoming Investor Conferences in August
More ▼
Key statistics
On Friday, Bioatla Inc (BCAB:NMQ) closed at 1.51, 21.77% above the 52 week low of 1.24 set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.57 |
---|---|
High | 1.63 |
Low | 1.38 |
Bid | 1.40 |
Offer | 1.65 |
Previous close | 1.52 |
Average volume | 1.02m |
---|---|
Shares outstanding | 48.12m |
Free float | 42.99m |
P/E (TTM) | -- |
Market cap | 72.66m USD |
EPS (TTM) | -2.49 USD |
Data delayed at least 15 minutes, as of May 31 2024 21:00 BST.
More ▼